MFDS
- Status: likely_approved
🇰🇷 Cedilanid D in South Korea
Cedilanid D (DESLANOSIDE) regulatory status in South Korea.
Marketing authorisation
Cedilanid D in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Cedilanid D approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Cedilanid D in South Korea?
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.